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Abstract
Objective/purpose The aim of the study was to assess the options of treatment and their related outcomes for chondral injuries in
the hip based on the available evidence whilst highlighting new and innovative techniques.
Methods A systematic review of the literature from PubMed (Medline), EMBASE, Google Scholar, British Nursing Index
(BNI), Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Allied and Complementary Medicine
Database (AMED) was undertaken from their inception to March 2017 using the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines. Clinical outcome studies, prospective/retrospective case series and case
reports that described the outcome of cartilage repair technique for the chondral injury in the hip were included. Studies on total
hip replacement, animal studies, basic studies, trial protocols and review articles were excluded.
Results The systematic review found 21 relevant papers with 596 hips. Over 80% of the included studies were published in or
after 2010. Most studies were case series or case reports (18 studies, 85.7%). Arthroscopy was used in 11 studies (52.4%). The
minimum follow-up period was six months. Mean age of the participants was 37.2 years; 93.5% of patients had cartilage injuries
of the acetabulum and 6.5% of them had injuries of the femoral head. Amongst the 11 techniques described in the systematic
review, autologous matrix-induced chondrogenesis, osteochondral autograft transplantation and microfracture were the three
frequently reported techniques.
Conclusion Over ten different techniques are available for cartilage repair in the hip, and most of them have good short- to
medium-term outcomes. However, there are no robust comparative studies to assess superiority of one technique over another,
and further research is required in this arena.
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Introduction
Isolated chondral and osteochondral defects within the hip
joint often present a technical challenge for the hip surgeon.
Common causes of cartilage damage in the hip include
femoroacetabular impingement (FAI), developmental dyspla-
sia, osteonecrosis, osteochondritis dissecans, loose bodies,
slipped capital femoral epiphysis, and trauma [1–5].
Amongst them, FAI has increasingly gained recognition as a
major cause of chondral injury and subsequent development
of arthritis in the hip joint [6–10]. In CAM FAI, the abnormal
contact between the aspherical femoral head-neck junction
and the acetabular rim results in a large amount of shear stress
being transmitted to the labro-chondral junction. Over a peri-
od of time, labral detachment and acetabular chondral damage
ensues [2, 11, 12]. On the other hand, the pincer FAI, in which
a deep or retroverted acetabulum makes contact with a
normal-shaped femoral neck, has a recognised pattern of dam-
age to the labrum, femoral head cartilage and a postero-medial
acetabular countercoup lesion [13]. Furthermore, in imaging
and surgical techniques like hip arthroscopy have led to in-
creased recognition of chondral lesions. The incidence of
chondral lesions at hip arthroscopy for FAI has been reported
to be up to 67.3% of the patients in one series [14].
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There is relatively little information about articular carti-
lage restoration in the hip when compared with what is known
about cartilage restoration in the knee. Currently, most carti-
lage repair methods for the hip are based on basic science and
strategies that were developed for the knee. Awareness of
young adult hip disease has been increasing in recent years,
and thus, the field of hip preservation continues to develop;
several new innovative techniques have been performed and
described in the literature. They include microfracture, autol-
ogous chondrocyte implantation (ACI), matrix-associated
chondrocyte implantation (MACI), autologous matrix-
induced chondrogenesis (AMIC), osteochondral autograft/
allograft transplantation, implantation of artificial plug, stick-
ing down of chondral flaps with fibrin adhesive and an intra-
articular injection of bone marrow mesenchymal stem cells
(BM-MSCs).
Currently, there is a gap in information particularly regard-
ing systematic reviews in the literature that provide hip sur-
geons with evidence-based recommendations, therefore, on
treating cartilage injuries in the hip. The aim of this study
was to provide the reader with options of treatment and their
related outcomes for chondral injuries in the hip based on the
available evidence whilst highlighting new and innovative
techniques involved in chondral repair.
Methods
Search strategy
Two reviewers (NN and CG) searched the online databases
(PubMed (Medline), EMBASE, Google Scholar, British
Nursing Index (BNI), Cumulative Index to Nursing and Allied
Health Literature (CINAHL) and Allied and Complementary
Medicine Database (AMED) for literature describing the out-
come of cartilage repair techniques for the chondral injury in the
hip. The Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines were used for designing
this study. A detailed search strategy is described in the
Appendix.
Study screening/data abstraction
The inclusion and exclusion criteria are shown in Table 1. Both
the reviewers independently abstracted the relevant study data
from the final pool of included articles and recorded this data
on a spreadsheet designed a priori. Participant-specific demo-
graphics extracted from each study included the number of
hips, gender distribution, mean age with range (years), length
of follow-up, location of the cartilage injury (acetabulum or
femoral head), surgical approach (open dislocation, arthrosco-
py or injection), cartilage restoration technique used in the
study, pre-operative condition of the damaged cartilage, final
outcome and specific comments (if any).
Statistics
The abstracted evidence was collected and analysed using
Microsoft Excel 2013 spread sheet. Statistical analysis in this
study focused on descriptive statistics.
Results
Flowchart of the literature search is shown in Fig. 1. The oldest
study included in this review was published in 2003, and over
80% of the included studies (17 out of 21 studies) were pub-
lished in or after 2010. Study demographics are shown in
Table 2. A total of 11 techniques were found from the system-
atic review: AMIC (5 studies), osteochondral autograft trans-
plantation (mosaicplasty) (5 studies), microfracture (4 studies),
artificial plug (TruFit®) (2 studies), fibrin adhesive (2 studies),
ACI (2 studies), debridement (1 study), MACI (1 study),
osteochondral allograft transplantation (1 study), direct carti-
lage suture repair (1 study) and intra-articular BM-MSC injec-
tion (1 study). Three studies described two techniques and com-
pared them to each other (microfracture and AMIC, 1 study;
MACI and AMIC, 1 study; ACI and debridement, 1 study).
Details of the 21 studies included are shown in Table 3.
Discussion
Our objective was to discuss the outcomes of the current strat-
egies for restoration of focal chondral injuries in the hip. This
study reviews all the cases of cartilage repair for the chondral
injuries in the hip (596 cases) reported in the English literature
and describes the outcomes of 11 techniques (including
debridement).
Table 1 Inclusion and exclusion criteria applied to articles identified in
the literature
Inclusion criteria
1. All levels of evidence
2. Written in the English language
3. Studies on humans
4. Studies reporting the outcome of cartilage repair techniques for
cartilage injuries in the hip
Exclusion criteria
1. Studies on other joints (e.g. knee)
2. Studies describing trial protocols without any results
3. Hip replacement surgery
4. Basic studies (e.g. cadaveric studies)
5. Reviews, systematic reviews
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Cartilage injuries in the hip have been previously shown to
result in poor long-term outcomes, including pain and early
secondary degenerative change followed by the subsequent de-
velopment of osteoarthritis [15, 16]. The current trend is to
focused on treating isolated cartilage damage and underlying
morphological pathology in younger patients in order to pre-
vent progression to end-stage degeneration. Although a number
of procedures for the management of chondral lesions in other
large joints (e.g. knee) have been reported, there currently re-
mains little information available for appropriate management
of these lesions in the hip [17]. All the techniques found in the
systematic review are described and discussed below.
Debridement
Debridement of a cartilage flap from a chondral injury may
allow symptoms to resolve and permit a return to activity or
sports [6, 18]. Arthroscopy is essential for the diagnosis of an
unstable flap if pre-operative imaging is unclear, and arthro-
scopic debridement is often the definitive therapy. Fontana
et al.. [19] carried out a controlled retrospective study of 30
patients (15 ACI, 15 arthroscopic debridements) affected by a
post-traumatic hip chondropathy (Outerbridge classification
grades 3–4, measuring 2 cm2 in area or more). The post-
operative Harris Hip Scores (HHS) in the ACI group were
significantly better than those in the debridement group.
Microfracture
Microfracture involves the use of an arthroscopic awl or drill
to perforate exposed subchondral bone to create multiple holes
and provide an entry portal for marrow-derived cells. The
rationale of the technique is to recruit mesenchymal stem cells
into the cartilage defect to create fibrocartilage. Following
microfracture, a marrow clot forms and provides the ideal
environment for mesenchymal stem cells to differentiate into
stable repair tissue [20]. The advantages of this technique are
that it is technically straightforward, can be performed
arthroscopically, without donor site morbidity, and has a low
cost. The disadvantage compared with other cartilage repair
techniques is that it produces less type II cartilage and has
different biomechanical properties than hyaline cartilage,
which may raise questions of its resilience and longevity
Fig. 1 Flowchart of the literature
search
Table 2 Demographics of the study
Parameter
Studies analysed 21 studies
Levels of evidence
3b 3 studies (14.3%)
4 18 studies (85.7%)
Participants (hips) 596
Male 216 (56.1%)
Female 169 (43.9%)
Unclear 211
Range of follow-up time 6–74 months
Mean participant age (range) 37.2 (15–63) years
Surgical approach
Arthroscopy 11 studies (52.4%)
Open 9 studies (42.9%)
Injection 1 study (4.8%)
Location of cartilage defect (participants)
Acetabulum 534 (93.5%)
Femoral head 37 (6.5%)
Unclear 25
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on
s.
T
he
ou
tc
om
e
w
as
si
gn
if
ic
an
tly
be
tte
r
in
th
e
A
M
IC
gr
ou
p
fo
r
bo
th
m
en
an
d
w
om
en
at
2,
3,
4
an
d
5
ye
ar
s,
ex
ce
pt
fo
r
w
om
en
5
ye
ar
s
po
st
-o
pe
ra
tiv
el
y.
A
to
ta
lo
f
6
pa
tie
nt
s
(7
.8
%
)
in
th
e
M
Fx
gr
ou
p
re
qu
ir
ed
T
H
R
at
a
m
ea
n
of
3.
2
ye
ar
s
(1
to
5)
po
st
-o
pe
ra
tiv
el
y.
N
on
e
in
th
e
A
M
IC
gr
ou
p
re
qu
ir
ed
T
H
R
.
20
14
G
ra
de
II
I
an
d
IV
(O
ut
er
br
id
ge
cl
as
si
fi
ca
tio
n)
ac
et
ab
ul
ar
ch
on
dr
al
le
si
on
s,
m
os
tly
lo
ca
te
d
in
th
e
su
pe
ri
or
ch
on
dr
al
ac
et
ab
ul
um
.P
at
ie
nt
s
w
ith
ac
et
ab
ul
ar
ch
on
dr
al
le
si
on
si
ze
be
tw
ee
n
2
an
d
4
cm
2
w
ith
ra
di
ol
og
ic
al
T
ön
ni
s
de
gr
ee
<
2.
Pa
rt
ia
lw
ei
gh
tb
ea
ri
ng
(3
0%
of
bo
dy
w
ei
gh
t)
on
th
e
op
er
at
ed
le
g
fo
r
3
w
ee
ks
.A
t4
w
ee
ks
po
st
-o
p,
w
al
ki
ng
w
ith
th
e
ai
d
of
1
cr
ut
ch
op
po
si
te
to
th
e
re
co
ve
ri
ng
le
g
w
as
al
lo
w
ed
fo
r
7
da
ys
,t
he
n
no
rm
al
w
al
ki
ng
th
er
ea
ft
er
.
In
bo
th
th
e
M
A
C
I
an
d
A
M
IC
gr
ou
ps
,s
ig
ni
fi
ca
nt
hi
p
sc
or
e
im
pr
ov
em
en
ts
w
er
e
m
ea
su
re
d
ov
er
ba
se
lin
e
le
ve
ls
at
6
m
on
th
s
po
st
-o
p
(8
1.
2
±
8.
4
fo
r
M
A
C
I,
80
.3
±
8.
3
fo
r
A
M
IC
,
bo
th
p
<
0.
00
1)
.S
ta
tis
tic
al
ly
si
gn
if
ic
an
t
di
ff
er
en
ce
s
be
tw
ee
n
th
e
gr
ou
ps
w
er
e
no
t
ob
se
rv
ed
.T
he
m
ea
n
m
H
H
S
im
pr
ov
em
en
ta
t
th
e
5-
ye
ar
fo
llo
w
-u
p
w
ith
re
sp
ec
tt
o
pr
e-
op
er
at
iv
e
le
ve
lw
as
37
.8
±
5.
9
an
d
39
.1
±
5.
9
in
pa
tie
nt
s
w
ho
un
de
rw
en
tM
A
C
I
an
d
A
M
IC
,r
es
pe
ct
iv
el
y
(n
ot
si
gn
if
ic
an
t)
.
N
o
fa
ilu
re
re
su
lti
ng
in
hi
p
ar
th
ro
pl
as
ty
w
as
de
te
ct
ed
in
an
y
of
th
es
e
pa
tie
nt
s
du
ri
ng
th
e
5-
ye
ar
fo
llo
w
-u
p
20
12
Fu
ll-
th
ic
kn
es
s
pa
ra
fo
ve
al
ch
on
dr
al
le
si
on
s
lo
ca
lis
ed
an
te
ro
la
te
ra
lt
o
th
e
fo
ve
a
co
nf
ir
m
ed
Pa
tie
nt
s
w
er
e
lim
ite
d
to
to
e-
to
uc
h
w
ei
gh
tb
ea
ri
ng
fo
r
ap
pr
ox
im
at
el
y
6
w
ee
ks
.A
ft
er
6
w
ee
ks
T
he
Te
gn
er
-L
ys
ho
lm
sc
or
e
at
la
te
st
fo
llo
w
-u
p
ra
ng
ed
fr
om
5
to
9
(m
ea
n,
7.
4)
.A
ll
pa
tie
nt
s
International Orthopaedics (SICOT)
T
ab
le
3
(c
on
tin
ue
d)
P
ub
lic
at
io
n
ye
ar
P
re
-o
pe
ra
tiv
e
co
nd
iti
on
Po
st
-o
pe
ra
tiv
e
re
ha
bi
lit
at
io
n
pr
ot
oc
ol
F
in
al
ou
tc
om
e
O
th
er
co
m
m
en
ts
at
th
e
tim
e
of
su
rg
ic
al
di
sl
oc
at
io
n.
T
he
le
si
on
si
ze
ra
ng
ed
fr
om
96
to
51
3
m
m
2
w
ith
a
m
ea
n
of
18
4
m
m
2
.
an
d
ra
di
og
ra
ph
ic
co
nf
ir
m
at
io
n
of
tr
oc
ha
nt
er
ic
un
io
n,
pr
og
re
ss
iv
e
w
ei
gh
tb
ea
ri
ng
w
as
en
co
ur
ag
ed
.
w
er
e
ab
le
to
re
tu
rn
to
th
ei
r
pr
e-
op
er
at
iv
e
le
ve
l
of
fu
nc
tio
n
w
ith
th
e
ex
ce
pt
io
n
of
pa
tie
nt
6
w
ho
se
co
nt
ra
la
te
ra
lh
ip
pr
ec
lu
de
d
pa
rt
ic
ip
at
io
n.
T
he
re
w
as
no
ob
vi
ou
s
as
ym
m
et
ri
c
jo
in
ts
pa
ce
na
rr
ow
in
g
vi
si
bl
e
on
an
A
P
pe
lv
is
vi
ew
in
an
y
of
th
e
pa
tie
nt
s.
20
12
Se
ve
re
os
te
oc
ho
nd
ra
ll
es
io
n
w
ith
a
su
bc
ho
nd
ra
l
cy
st
on
th
e
fe
m
or
al
he
ad
se
en
on
M
R
I.
R
es
tr
ic
te
d
w
ei
gh
tb
ea
ri
ng
du
ri
ng
4
w
ee
ks
(w
al
ki
ng
w
ith
cr
ut
ch
es
an
d
pl
an
ta
r
to
uc
h)
.
M
R
I
sc
an
ni
ng
at
6
m
on
th
s
sh
ow
ed
th
e
T
ru
Fi
t
pl
ug
in
si
tu
,w
ith
ou
ts
ub
si
de
nc
e,
w
hi
ls
tt
he
re
st
ill
is
an
ir
re
gu
la
ri
ty
on
th
e
bo
rd
er
of
th
e
ar
tic
ul
ar
ca
rt
ila
ge
su
rf
ac
e.
A
t6
m
on
th
s,
th
e
ri
gh
th
ip
sh
ow
ed
an
ab
du
ct
io
n
of
35
°,
a
sy
m
m
et
ri
c
en
do
ro
ta
tio
n
an
d
ex
or
ot
at
io
n
of
30
°
an
d
an
ad
du
ct
io
n
of
10
°.
Fl
ex
io
n
w
as
95
°,
co
m
pa
re
d
to
11
0°
at
th
e
co
nt
ra
la
te
ra
ls
id
e.
20
12
L
ar
ge
(>
2
cm
2
)
fe
m
or
al
he
ad
or
ac
et
ab
ul
ar
ch
on
dr
al
or
os
te
oc
ho
nd
ra
ll
es
io
ns
.A
ll
w
er
e
cl
as
si
fi
ed
as
IC
R
S
gr
ad
e
3
or
4
le
si
on
s
an
d
T
ӧn
ni
s
gr
ad
e
<
2.
N
ot
m
en
tio
ne
d
Po
st
-o
pe
ra
tiv
e
O
xf
or
d
H
ip
Sc
or
es
ra
ng
ed
fr
om
13
to
17
,U
C
L
A
A
ct
iv
ity
Sc
or
es
ra
ng
ed
fr
om
5
to
10
an
d
M
O
C
A
R
T
sc
or
es
ra
ng
ed
fr
om
55
to
75
.
Tw
o
pa
tie
nt
s
(3
3%
)
w
er
e
lo
st
to
fo
llo
w
-u
p.
20
12
2
cm
×
5
to
8
m
m
ar
ea
of
os
te
oc
ho
nd
ra
ld
ef
ec
ti
n
pa
tie
nt
1
an
d
1
×
2
cm
ar
ea
of
os
te
oc
ho
nd
ra
l
de
fe
ct
in
pa
tie
nt
2.
B
ot
h
de
fe
ct
s
w
er
e
in
th
e
an
te
ro
su
pe
ri
or
w
ei
gh
t-
be
ar
in
g
po
rt
io
n
of
th
e
fe
m
or
al
he
ad
.
Pa
tie
nt
s
w
er
e
ke
pt
pa
rt
ia
lw
ei
gh
tb
ea
ri
ng
fo
r
2
m
on
th
s
af
te
r
su
rg
er
y
an
d
th
en
w
er
e
gr
ad
ua
lly
re
tu
rn
ed
to
fu
ll
w
ei
gh
tb
ea
ri
ng
s.
M
R
I
at
6
m
on
th
s
sh
ow
ed
co
m
pl
et
e
in
co
rp
or
at
io
n
of
th
e
os
te
oc
ho
nd
ra
lp
lu
gs
in
to
th
e
fe
m
or
al
he
ad
.A
t4
ye
ar
s
fo
llo
w
-u
p,
pa
tie
nt
1
ha
d
m
H
H
S
96
,H
O
S
10
0
an
d
pa
tie
nt
2
ha
d
m
H
H
S
10
0,
H
O
S
10
0.
R
ad
io
gr
ap
hs
sh
ow
ed
he
te
ro
to
pi
c
os
si
fi
ca
tio
n
po
st
-o
pe
ra
tiv
el
y
in
bo
th
of
th
e
pa
tie
nt
s.
20
12
Fu
ll-
th
ic
kn
es
s
ac
et
ab
ul
ar
ch
on
dr
al
de
fe
ct
s
in
th
e
su
pe
ri
or
an
d
an
te
ro
su
pe
ri
or
zo
ne
s
of
th
e
ac
et
ab
ul
um
(a
ve
ra
ge
15
4m
m
2
,r
an
ge
48
–3
00
m
m
2
)
Fo
r
th
e
fi
rs
t6
w
ee
ks
,o
nl
y
fo
ot
-f
la
tn
on
-w
ei
gh
t
be
ar
in
g
w
as
al
lo
w
ed
.F
ul
lw
ei
gh
tb
ea
ri
ng
w
as
ac
hi
ev
ed
ov
er
th
e
fo
llo
w
in
g
2
w
ee
ks
.
T
he
m
ea
n
N
A
H
S
im
pr
ov
ed
fr
om
55
to
78
.
E
xc
lu
di
ng
1
pa
tie
nt
w
ho
on
ly
ha
d
a
25
%
fi
ll,
19
of
th
e
20
pa
tie
nt
s
ha
d
a
m
ea
n
fi
ll
of
96
%
(r
an
ge
,7
5–
10
0%
)
w
ith
m
ac
ro
sc
op
ic
al
ly
go
od
qu
al
ity
(g
ra
de
1)
re
pa
ir
tis
su
e
as
pe
r
B
le
vi
ns
et
al
.’s
cl
as
si
fi
ca
tio
n.
20
12
Po
st
-t
ra
um
at
ic
hi
p
ch
on
dr
op
at
hy
of
gr
ad
e
3
or
4
ac
co
rd
in
g
to
th
e
O
ut
er
br
id
ge
cl
as
si
fi
ca
tio
n,
m
ea
su
ri
ng
2
cm
2
in
ar
ea
or
m
or
e.
T
he
m
ea
n
si
ze
of
th
e
de
fe
ct
w
as
2.
6
cm
2 .
N
on
-w
ei
gh
tb
ea
ri
ng
fo
r
4
w
ee
ks
.P
ar
tia
ll
oa
d
w
as
al
lo
w
ed
af
te
r
4
w
ee
ks
in
gr
ou
p
A
(A
C
I)
an
d
af
te
r
2
w
ee
ks
in
gr
ou
p
B
(d
eb
ri
de
m
en
t)
.
T
he
pa
tie
nt
s
w
ho
un
de
rw
en
tA
C
I
(g
ro
up
A
)
im
pr
ov
ed
af
te
r
th
e
pr
oc
ed
ur
e
co
m
pa
re
d
w
ith
th
e
gr
ou
p
th
at
un
de
rw
en
td
eb
ri
de
m
en
ta
lo
ne
(g
ro
up
B
).
T
he
m
ea
n
H
H
S
pr
e-
op
er
at
iv
el
y
w
as
48
.3
(9
5%
co
nf
id
en
ce
in
te
rv
al
,4
5.
4
to
51
.2
)
in
gr
ou
p
A
an
d
46
(9
5%
C
I,
42
.7
to
49
.3
)
in
gr
ou
p
B
(n
o
si
gn
if
ic
an
td
if
fe
re
nc
e)
.
T
he
fi
na
lH
H
S
w
as
87
.4
(9
5%
C
I,
84
.3
to
90
.5
)
in
gr
ou
p
A
an
d
56
.3
(9
5%
C
I,
54
.4
to
58
.7
)
in
gr
ou
p
B
(p
<
0.
00
1)
.
20
12
T
he
ra
di
og
ra
ph
s
di
sp
la
ye
d
a
ch
on
dr
al
de
fe
ct
in
th
e
su
pe
ro
la
te
ra
la
sp
ec
to
f
th
e
fe
m
or
al
he
ad
.
Pr
e-
op
er
at
iv
e
H
H
S
w
as
43
.
N
ot
m
en
tio
ne
d
m
H
H
S
im
pr
ov
ed
fr
om
43
to
96
at
24
w
ee
ks
.A
t
a
3-
ye
ar
fo
llo
w
-u
p,
th
e
pa
tie
nt
w
as
sy
m
pt
om
-f
re
e
w
ith
ne
ar
co
m
pl
et
e
in
co
rp
or
at
io
n
of
th
e
gr
af
tr
ad
io
gr
ap
hi
ca
lly
.
T
he
pa
tie
nt
ha
d
pa
st
hi
st
or
y
of
Pe
rt
he
s
di
se
as
e.
20
11
D
el
am
in
at
ed
ac
et
ab
ul
ar
ar
tic
ul
ar
ca
rt
ila
ge
(A
po
si
tiv
e
‘w
av
e
si
gn
’
at
th
e
ch
on
dr
ol
ab
ra
l
To
e-
to
uc
h
w
ei
gh
tb
ea
ri
ng
w
ith
cr
ut
ch
es
is
ad
vi
se
d
fo
r
4
w
ee
ks
.
m
H
H
S
fo
rp
ai
n
im
pr
ov
ed
si
gn
if
ic
an
tly
fr
om
21
.8
(9
5%
C
I
19
.0
to
24
.7
)
pr
e-
op
er
at
iv
el
y
to
35
.8
(9
5%
C
I
32
.6
to
38
.9
)
po
st
-o
pe
ra
tiv
el
y
T
he
re
w
er
e
3
pa
tie
nt
s
w
ho
re
qu
ir
ed
fu
rt
he
r
ar
th
ro
sc
op
ic
in
te
rv
en
tio
ns
fo
r
pe
rs
is
te
nt
sy
m
pt
om
s,
cr
ea
te
d
by
ili
op
so
as
ir
ri
ta
tio
n.
A
t
International Orthopaedics (SICOT)
T
ab
le
3
(c
on
tin
ue
d)
P
ub
lic
at
io
n
ye
ar
P
re
-o
pe
ra
tiv
e
co
nd
iti
on
Po
st
-o
pe
ra
tiv
e
re
ha
bi
lit
at
io
n
pr
ot
oc
ol
F
in
al
ou
tc
om
e
O
th
er
co
m
m
en
ts
ju
nc
tio
n
in
di
ca
te
d
de
la
m
in
at
io
n
of
ar
tic
ul
ar
ca
rt
ila
ge
fr
om
th
e
su
bc
ho
nd
ra
lb
on
e)
.
(p
<
0.
00
01
).
T
he
M
H
H
S
fo
r
fu
nc
tio
n
al
so
sh
ow
ed
si
gn
if
ic
an
t,
al
th
ou
gh
m
or
e
m
od
es
t,
im
pr
ov
em
en
ts
fr
om
40
.0
(9
5%
C
I
37
.7
to
42
.3
)
pr
e-
op
er
at
iv
el
y
to
43
.6
(9
5%
C
I
41
.4
to
45
.8
)
po
st
-o
pe
ra
tiv
el
y
(p
=
0.
00
06
).
T
he
re
w
er
e
3
pa
tie
nt
s
w
ho
ha
d
ea
rl
y
(w
ith
in
12
m
on
th
s
of
th
e
in
de
x
pr
oc
ed
ur
e)
re
vi
si
on
ar
th
ro
sc
op
y
fo
r
ili
op
so
as
pa
th
ol
og
y.
ea
ch
of
th
es
e
pr
oc
ed
ur
es
,t
he
pr
ev
io
us
ly
re
pa
ir
ed
ar
tic
ul
ar
ca
rt
ila
ge
w
as
se
en
to
be
in
go
od
co
nd
iti
on
.
20
11
18
×
18
m
m
is
ol
at
ed
de
fe
ct
of
th
e
su
pe
ri
or
ac
et
ab
ul
ar
do
m
e
in
pa
tie
nt
1
an
d
12
m
m
di
am
et
er
×
10
m
m
de
ep
os
te
oc
ho
nd
ra
ld
ef
ec
t
in
th
e
w
ei
gh
t-
be
ar
in
g
do
m
e
of
th
e
su
pe
ri
or
ac
et
ab
ul
um
in
pa
tie
nt
2
E
ig
ht
w
ee
ks
of
pr
ot
ec
te
d
w
ei
gh
tb
ea
ri
ng
A
n
M
R
I
at
18
m
on
th
s
in
bo
th
ca
se
s
de
m
on
st
ra
te
d
in
co
rp
or
at
io
n
of
th
e
al
lo
gr
af
t
bo
ne
in
to
th
e
ho
st
ac
et
ab
ul
um
.A
t2
4
m
on
th
s
in
pa
tie
nt
1
an
d
42
m
on
th
s
in
pa
tie
nt
2,
ra
di
og
ra
ph
s
sh
ow
ed
no
pr
og
re
ss
iv
e
jo
in
t
sp
ac
e
na
rr
ow
in
g
co
m
pa
re
d
to
pr
e-
op
er
at
iv
e
ra
di
og
ra
ph
s.
Pa
tie
nt
1
ha
d
im
pr
ov
em
en
ti
n
m
H
H
S
fr
om
75
pr
e-
op
er
at
iv
el
y
to
97
at
2
ye
ar
s
fo
llo
w
-u
p.
m
H
H
S
im
pr
ov
ed
fr
om
79
pr
e-
op
er
at
iv
el
y
to
10
0
at
th
e
tim
e
of
3
ye
ar
s
fo
llo
w
-u
p
in
pa
tie
nt
2.
B
ot
h
pa
tie
nt
s’
H
O
S
su
bs
et
s
fo
r
ac
tiv
iti
es
of
da
ily
liv
in
g
an
d
sp
or
ts
sc
or
e
w
er
e
10
0
po
in
ts
ea
ch
.
Pa
tie
nt
2
ha
d
2
pr
ev
io
us
op
en
hi
p
op
er
at
io
ns
fo
r
fi
br
ou
s
dy
sp
la
si
a.
20
11
In
tr
a-
op
er
at
iv
el
y,
th
e
m
ea
n
ar
ea
of
ca
rt
ila
gi
no
us
da
m
ag
e
on
th
e
fe
m
or
al
he
ad
w
as
4.
8
cm
2
(3
–9
cm
2
).
Pa
tie
nt
s
w
er
e
ke
pt
no
n-
w
ei
gh
tb
ea
ri
ng
fo
r
6
w
ee
ks
an
d
th
en
pr
og
re
ss
ed
to
w
ei
gh
t
be
ar
in
g
as
to
le
ra
te
d.
H
H
S
in
cr
ea
se
d
fr
om
52
.8
(3
5–
74
)
to
79
.5
po
in
ts
(6
5–
93
).
T
he
O
xf
or
d
H
ip
S
co
re
de
cr
ea
se
d
in
di
ca
tin
g
fu
nc
tio
n
im
pr
ov
em
en
tf
ro
m
34
.5
po
in
ts
(2
2–
48
)
to
19
.2
po
in
ts
(1
4–
26
).
A
t
la
te
st
fo
llo
w
-u
p,
al
la
ut
og
ra
ft
pl
ug
s
ap
pe
ar
ed
to
be
w
el
li
nc
or
po
ra
te
d
on
ra
di
ol
og
ic
al
ex
am
in
at
io
n.
C
T-
ar
th
ro
gr
ap
hy
at
6
m
on
th
s
re
ve
al
ed
in
ta
ct
ca
rt
ila
ge
ov
er
th
e
pl
ug
s
w
ith
sm
oo
th
in
te
rf
ac
es
be
tw
ee
n
th
e
ar
tic
ul
at
in
g
bo
ne
s
in
al
lc
as
es
.
N
o
T
H
R
w
as
re
qu
ir
ed
by
th
e
tim
e
of
th
e
la
st
fo
llo
w
-u
p.
20
11
C
T
co
nf
ir
m
ed
th
e
pr
es
en
ce
of
so
lit
ar
y
su
bc
ho
nd
ra
lc
ys
ts
in
th
e
w
ei
gh
t-
be
ar
in
g
po
rt
io
n
of
th
e
ac
et
ab
ul
um
in
al
l4
pa
tie
nt
s.
Pa
tie
nt
1
w
as
al
so
fo
un
d
to
ha
ve
su
bc
ho
nd
ra
l
cy
st
s
on
th
e
op
po
si
ng
su
rf
ac
e
of
th
e
fe
m
or
al
he
ad
an
d
a
la
br
al
te
ar
.
Pa
tie
nt
s
w
er
e
m
ob
ili
se
d
50
%
w
ei
gh
tb
ea
ri
ng
w
ith
cr
ut
ch
es
fo
r
th
e
fi
rs
t6
w
ee
ks
.T
hi
s
w
as
gr
ad
ua
lly
in
cr
ea
se
d
to
fu
ll
w
ei
gh
tb
ea
ri
ng
by
8
w
ee
ks
.
T
he
m
ea
n
N
A
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[20]. Also, the concentration of mesenchymal cells in the bone
marrow is relatively low and their chondrogenic potential de-
clines with age [21]. Philippon et al. [22] reported the outcome
of microfracture in nine patients with a full-thickness chondral
defect of the acetabulum. The average percent fill of the ace-
tabular chondral lesions at second-look arthroscopy was 91%,
and eight of the nine patients had grade 1/2 repair product at
second look. Karthikeyan et al. [23] described the outcome of
20 patients who underwent arthroscopic surgery for FAI with
a localised full-thickness acetabular chondral defect which
were treated by microfracture. At an average follow-up of
17 months, 19 of the 20 patients had a mean fill of 96% with
macroscopically good quality repair tissue. Zaltz and Leunig
[24] reviewed ten patients with symptomatic FAI diagnosed
with parafoveal chondral defects confirmed at the time of
surgical dislocation. Seven of the ten patients were treated
by microfracture (other 3 were treated by AMIC), and all the
patients were able to return to their pre-operative level of
function with the exception of one patient who had a problem
in the contralateral hip. At the last follow-up, there was no
obvious asymmetric joint space narrowing visible on an AP
pelvis view in any of the patients. Fontana et al. [25] compared
the outcome of 77 patients who had a microfracture and 70
patient who had AMIC for cartilage injuries in the hip.
Although the outcome in both groups significantly improved
at six months and one year post-operatively, the outcome in
the microfracture group slowly deteriorated four years after
surgery, whilst that in the AMIC group remained stable.
Autologous chondrocyte implantation
ACI includes the harvest of chondrocytes with growth and
expansion at an off-site facility, followed by reimplantation
of the cells into the affected area. ACI is indicated for symp-
tomatic, well-contained defects that are between 2 and 10 cm2
and with less than 6–8 mm of bone loss [26]. Most surgeons
who performACI regularly are now using a synthetic collagen
membrane to cover the implanted chondrocytes [19, 27].
Ellender and Minas [27] presented a clinical case and de-
scribed ACI for a femoral head chondral defect of 10 cm2 in
a 19-year-old female college student who had progression of
disease after prior mosaicplasty. Two years after ACI, she
remained free of pain. Her post-operative contrast-enhanced
MRI demonstrated repair tissue fill and radiographs showed a
normal joint space without any sign of change.
Matrix-associated chondrocyte implantation
MACI is a second-generation ACI technique that utilises ab-
sorbable scaffolds to support the implanted chondrocytes dur-
ing healing. Theoretically, it should restore hyaline cartilage at
the defect. Unfortunately, same as ACI, it is a two-stage pro-
cedure where chondrocytes are harvested from the patient,
cultured and then returned to the patient via open surgical
dislocation of the hip which is a technically demanding surgi-
cal approach. Mancini and Fontana [28] assessed and com-
pared the clinical outcomes of arthroscopic MACI and AMIC
for the treatment of acetabular chondral defects between 2 and
4 cm2 consequent to FAI. In both groups, significant improve-
ment in modified HHS (mHHS) was measured over baseline
levels at six months post-operation. It continued to improve up
to three years post-operation and remained stable until five
years follow-up. There was no statistically significant differ-
ence between the two groups.
Autologous matrix-induced chondrogenesis
AMIC is a novel single-step procedure in which the
microfracture technique has been enhanced by the use of a
collagen matrix. The Chondro-Gide matrix is placed in the
defect and a porcine collagen I/III matrix is sewn over the
lesion to stabilise the fragile blood clot that arises from the
microfracture to provide a stable infrastructure for the forma-
tion of repair tissue [29]. No cells have to be harvested, cul-
tured and re-implanted in AMIC. Therefore, there is no har-
vest site morbidity, and the operation can be performed as a
single procedure. Moreover, AMIC does not require complex
cell expansion techniques. Other than comparative studies
with microfracture [24, 25] or MACI [28] described above,
Leunig et al. [30] reported six patients with AMIC using sur-
gical dislocation of the hip. No complications occurred, and
good post-operative outcome scores were reported. Fontana
[31] treated 201 patients with AMIC arthroscopically for
Outerbridge grade III/IV chondral lesions of the acetabulum.
Modified HHS improved significantly at six months post-
operatively in comparison with pre-operative levels, reaching
the highest level of improvement at the three year follow-up.
Osteochondral autograft transplantation
(mosaicplasty)
Mosaicplasty involves transplanting healthy, mature cartilage
from a non-weight-bearing part of the hip or knee to an artic-
ular defect. The transplanted cartilage integrates with the ad-
jacent host cartilage via fibrocartilage [32]. The inferior aspect
of the femoral head, the femoral head-neck junction and the
periphery of the femoral trochlea of the knee can be the po-
tential donor sites. Mosaicplasty offers many potential advan-
tages, including the ability to transfer new mature hyaline
cartilage into the defect in a single-stage procedure and the
absence of potential disease transmission, which can occur in
allograft transplantation. On the contrary, owing to the autol-
ogous nature of this technique, it is limited by donor site
morbidity, graft availability and the potential for dead space
between the grafts [32]. Hart et al. [33] first reported the case
of an osteochondral defect of the femoral head and subsequent
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treatment using mosaicplasty with open surgical dislocation of
the hip. At six months following surgery, the patient had a full
range of painless movement of the hip with no further com-
plaints of pain related to activities. Emre et al. [34] also pre-
sented a case where the defect of the femoral head was treated
with surgical dislocation of the hip and mosaicplasty. The
patient was symptom-free with nearly complete incorporation
of the graft radiologically at three years after the operation.
Nam et al. [35] reported two cases of a chondral defect on the
femoral head after a traumatic hip dislocation, treated with
mosaicplasty from the ipsilateral knee, and the inferior femo-
ral head, respectively. At 1 and five years of follow-up, MRI
showed good autograft incorporation with the maintenance of
articular surface conformity. Krych et al. [36] reported two
cases of post-traumatic osteochondral defects of the femoral
head. Both the patients were treated with mosaicplasty from
the ipsilateral knee to the femoral head, with successful clin-
ical and radiological results at a mean follow-up of 4.3 years.
Girard et al. [37] treated 10 patients for femoral cartilage de-
fects by mosaicplasty of the femoral head through a trochan-
teric flip osteotomy with surgical dislocation of the hip. At the
mean follow-up of 29.2 months, clinical score and range of
motion improved significantly. All radiological investigations
at the latest follow-up showed that the grafts were well-
incorporated at the site of mosaicplasty with intact cartilage
over them and smooth interfaces between articulating bony
surfaces.
Osteochondral allograft transplantation
Mosaicplasty has been shown to be a useful procedure, but
there can be donor site morbidity and there is a limit to the
size of the treatable defect. Allograft transplantation can
also be a successful solution for the treatment of cartilage
defects. It offers not only the potential advantages of trans-
ferring immediate functional hyaline cartilage but also the
ability to resurface a large area without associated donor site
morbidity. Potential allograft donor sources for defects
within the acetabular side of the hip were a cadaveric ace-
tabulum or medial tibial plateau. Cartilage is relatively
immunoprivileged and avascular; thus, the host immune
reaction is considered to be limited [38]. Allograft bone
becomes necrotic and is reabsorbed via creeping substitu-
tion during the healing process. This provides a scaffold and
supports the articular surface as part of gradual incorpora-
tion [39]. In the systematic review, Krych et al. [40] reported
thei r exper ience in two pat ients who underwent
osteochondral allograft transplantation for the acetabular
cartilage defects. MRI at 18 months in both cases demon-
strated incorporation of the graft into the host acetabulum.
Hip Outcome Scores (HOS) were 100 points each in both
patients two years post-operatively.
Direct cartilage suture repair
Delamination is a full-thickness cartilage separation from the
underlying subchondral bone, which forms an unstable flap at
risk for complete detachment [41]. Our review found a case
report that presented direct cartilage repair as a possible tech-
nique to treat large delaminated full-thickness acetabular carti-
lage repairs. Sekiya et al. [42] described a case of a 17-year-old
boy presented with bilateral hip pain because of bilateral CAM-
type FAI and a 1-cm delaminated unstable cartilage flap in the
anterior-superior acetabulum. Arthroscopic microfracture un-
derneath the flap of anterior-superior acetabular cartilage and
an absorbable monofilament suture repair of the cartilage was
conducted. At two years post-operatively, the patient reported
95% of normal function for both hips. Overall, the patient was
satisfied with the outcome including a score of 96 on the
mHHS, 93 on the HOS Activities of Daily Living subscale
and 81 on the HOS Sports subscale at the final follow-up.
Fibrin adhesive
The earliest stage in the formation of an articular cartilage flap is
delamination of the overlying articular cartilage from the un-
derlying subchondral bone [43]. Particularly, if the articular
cartilage itself may contain a significant number of viable
chondrocytes, debriding such an area of chondral instability
seems an unnecessary surgical procedure. Fibrin adhesive is a
biological substance, which has already been used in general
surgery, ophthalmology, neurosurgery, otolaryngology and or-
thopaedics, thanks to its adhesive properties [44–48]. This pro-
cedure involved creating an incision at the periphery of the
acetabular labrum and passing an awl underneath to create
microfracture. Fibrin glue was inserted between subchondral
bone and delaminated cartilage, and the cartilage was pressed
down until the adhesive had set. Tzaveas and Villar [49]
analysed the efficacy of using fibrin adhesive for arthroscopic
repair of chondral delamination lesions with intact gross carti-
lage structure in 19 patients. Mean mHHS was improved sig-
nificantly after surgery, and in all five patients who underwent
revision arthroscopy at a later date, the chondral repair appeared
intact. Stafford et al. [50] reported the results of 43 patients with
FAI who have undergone fibrin adhesive technique for re-
attachment of delaminated chondral flaps. Both mHHS for pain
and function improved significantly after the operation. In three
patients who required further arthroscopic interventions for per-
sistent symptoms created by iliopsoas irritation, the previously
repaired articular cartilage was found in a good condition.
Intra-articular BM-MSC injection
Adult MSCs were originally believed to only differentiate into
tissue-specific cells. However, these cells were recently proven to
have the ability to differentiate into a different tissue in response
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to specific signals released by the site of injury, including carti-
lage injury [51, 52]. Adding to animal studies, several authors
reported on intra-articular injection ofMSCs into the knee for the
treatment of cartilage defects and showed good results with re-
gard to pain and clinical outcomes [53–56]. Injected MSCs were
incorporated into the articular cartilage of the injected joint. They
integrate into the surface of the cartilage and also the interior of
the cartilage [52]. Mardones et al. [57] first reported the outcome
of intra-articular BM-MSC injection for the cartilage injury in the
hip. Three intra-articular injections of 20 × 106 BM-MSCs were
conducted from four to six weeks post-operatively in 29 hips that
received hip arthroscopy for FAI and focal cartilage injuries.
Clinical outcome scores and VAS improved significantly after
surgery, and no major complications had been reported at the
time of the last follow-up.
Artificial plug
The systematic review found two articles that used an artificial
plug, and both of them utilise the TruFit cartilage/bone (CB) plug
(Smith & Nephew). It is a resorbable polymer scaffold that can
be inserted into osteochondral defects, which acts as a scaffold
that provides structural support. Also, native marrow elements
can migrate into the plug to promote bone in-growth as well as
articular cartilage regeneration. Field et al. [58] described the use
of TruFit for the treatment of acetabular cystic cartilage lesions in
four patients. Patients underwent hip arthroscopy followed by the
antegrade insertion of a plug through the ilium until the surface of
the plug coincided with the articular surface. At ten months fol-
low-up, patients reported increased function and improvement in
Non-Arthritic Hip Score (NAHS). CT and MRI showed incor-
poration and continued healing of the plug six months post-op-
eratively. Vundelinckx et al. [59] reported a case of a 34-year-old
employee (gender was not described) who underwent TruFit for
an osteochondral injury of the femoral head. MRI at six months
showed the TruFit was placed in situ whilst there was an irregu-
larity on the border of the articular cartilage surface. They men-
tioned it was very difficult to interpret early MRI images of
ingrowth of TruFit plugs, as described by authors of past radio-
graphic studies [60].
Of the 21 studies found in the systematic review, only 3 stud-
ies are level IIIb (retrospective comparative study) and the rest
were level IV (case series/report). Two studies described superi-
ority of one cartilage repair method over another [19, 25], and
one study showed there was no difference in clinical outcome
between two methods [28]. Fontana’s study [19] was limited by
the reduced number of patients and the lack of an objective
method for the evaluation of the results. Other limitations are
the criteria for patient inclusion and selection bias in the
randomisation process. Fontana’s study [25] andMancini’s study
[28] were also limited by the lack of randomisation, and clinical
outcomes were only assessed using the mHHS.
The strengths of this systematic review include the pursuit of
knowledge in an important novel area of investigation and a
rigorous methodological approach. Regarding the methodologi-
cal approach, a broad-based and comprehensive literature search
of multiple databases with multiple reviewers allowed for a very
inclusive approach to capture the vast majority of existing liter-
ature. Nonetheless, there are limitations which include the inclu-
sion of English only studies and the overall low level of evidence
available in the included studies on this topic (mostly level IIIb
and IV studies). Retrospective designs are prone to data inaccu-
racy as well as missing information, which subject them to se-
lection and detection bias. Without a doubt, this diminishes the
accuracy of the data collected and, therefore, limits the quality of
a systematic review, whilst this current level of evidence reflects
the novel and emerging nature of cartilage repair strategies in the
hip joint. Additionally, our results include a wide spectrum of
pathologies and methods of treatment, which also made drawing
conclusions and giving specific guidelines difficult. Furthermore,
pre-operative condition and post-operative rehabilitation protocol
were different in each study, which made comparison among
studies difficult as well. Future studies should address compara-
tive effectiveness of the various treatment options, and long-term
registry-based studies that report patient reported outcomes and
radiographic outcomes will help inform treatment decisions.
Conclusion
Although there are many different cartilage restoration tech-
niques available, current best evidence does not support any
one surgical technique as a superior method for treating carti-
lage injuries in the hip. Unfortunately there remains a paucity
of randomised trials with long-term follow-up, which makes it
difficult to perform a meaningful assessment of the outcome
of each procedure. Of the 21 studies found in the systematic
review, AMIC, mosaicplasty and microfracture were relative-
ly well-reported, though they were only described in very
limited case series. Also, only two studies described superior-
ity of one cartilage repair method over another—one showed
superiority of AMIC over microfracture [25] and another
showed superiority of ACI over debridement [19], and one
study showed that there was no statistically significant differ-
ence between MACI and AMIC in terms of post-operative
mHHS [28]. To make any specific recommendations for or-
thopaedic surgeons with regards to treatment decisions, ade-
quately powered long-term large-scale high-quality
randomised-control trials focusing on two or three specific
methods of treatment need to be conducted in the future.
Contribution of authors VK takes responsibility for the integ-
rity of the work as a whole, from inception to the finished
manuscript. NN, CG, AD, OA and VK were responsible for
the conception and design; NN, CG and VK for the collection,
International Orthopaedics (SICOT)
assembly, analysis and interpretation of data; NN, OA and VK
for drafting; and NN, CG, AD, OA and VK for the final
approval of the manuscript and for the critical revision for
important intellectual contents.
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict of
interest.
Ethical approval This article does not contain any studies with human
participants.
Appendix
Search strategy
Two reviewers (NN and CG) searched the online databases
(PubMed (Medline), EMBASE, Google Scholar, BNI,
CINAHL and AMED) for literature describing the outcome of
cartilage repair techniques for the chondral injury in the hip. The
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines were used for designing this
study. Database search was conducted on 1st March 2017 and
retrieved articles from database inception to the search date. The
research question and individual study eligibility criteria were
established a priori. We used medical subject headings including
the following key search terms: hip, cartilage, chondral, repair,
regeneration, restoration, refixation, implantation, chondroplasty
and chondrogenic. Terms were connected by the Boolean oper-
ators ‘AND’ and ‘OR’. Levels I, II, III, IV and V evidence (ac-
cording to the Oxford Centre for Evidence-Based Medicine)
English-language studies were eligible for inclusion in the sys-
tematic review. The search also included the yet to be printed
search results. Results were pooled, and duplicate searches were
excluded by having two reviewers (NN and CG) independently
review all the titles and abstracts. Both of the reviewers had been
trained in a field of clinical research and had enough experience
at the stage of abstract screening and manuscript review. Any
discrepancies at the title and abstract stage were resolved by
automatic inclusion to ensure thoroughness. The remaining
search results were divided equally between two reviewers
(NN and CG) and reviewed in duplicate applying the inclusion
and exclusion criteria. Any discrepancies at the full-text stage
were resolved by consensus between the two reviewers. If a
consensus could not be reached, a third more senior reviewer
(VK) was consulted to resolve the discrepancy. Also, for quality
control, VK reviewed a 25% random sample of excluded studies
and all included title and abstracts.
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